Back to Search
PREMA PEETHAMBARAM, M.D.
M.D.
Medical Oncology Physician
NPI: 1760460505IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
37044(MN)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
37044(MN)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1985
Research & Publications (12)
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy.
PMID 12694661·Gynecol Oncol·2003
8-other
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Centering prayer for women receiving chemotherapy for recurrent ovarian cancer: a pilot study.
PMID 19581232·Oncol Nurs Forum·2009
3-trial
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
PMID 16879607·Eur J Haematol·2006
4-observational
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer.
PMID 15999272·Cancer Chemother Pharmacol·2005
3-trial
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.
PMID 15756013·Clin Cancer Res·2005
3-trial
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
PMID 15517589·Cancer·2004
3-trial
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
PMID 15370254·Leuk Lymphoma·2004
8-other
A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma.
PMID 14716767·Cancer·2004
3-trial
Pelvic primitive neuroectodermal tumor associated with a cluster of small round cell tumors: case report and review of current literature.
PMID 14529689·Gynecol Oncol·2003
5-case
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors.
PMID 10764436·J Clin Oncol·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1760460505
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 12
Are you this provider?
Claim Your Profile